ReutersGSK shingles vaccine shows benefits across all age groupsReutersLONDON (Reuters) - An experimental shingles vaccine from GlaxoSmithKline is effective across all age groups, researchers said on Tuesday, boosting the prospects of a key product in the British drugmaker's development pipeline. In contrast to Merck's ...GlaxoSmithKline's shingles vaccine gets a leg up on Merck's rival with a PhIII winFierceBiotechJim Cramer on Agenus (AGEN) Stock: 'I Still Like It'TheStreet.comGSK Shingles Vaccine Demonstrates 97.2% Efficacy in Phase 3 StudyDrug Discovery & DevelopmentStreetInsider.com -Sydney Morning Heraldall 23 news articles »
GSK shingles vaccine shows benefits across all age groups
Rating: 4.5
Diposkan Oleh: Unknown
